|
|
| | 2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- Basic information |
| | 2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- Chemical Properties |
| density | 1.318±0.06 g/cm3(Predicted) | | pka | 9.54±0.40(Predicted) |
| | 2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- Usage And Synthesis |
| Uses | Razpipadon ((-)-PW0464), an aromatic compound, is a dopamine receptor partial agonist. Razpipadon can be used in the study of dopamine D1 ligand-mediated related psychiatric disorders[1][2]. | | IC 50 | D1 Receptor | | References | [1] Michael Aaron Brodney, et al. Heteroaromatic compounds and their use as dopamine d1 ligands. WO2014207601. [2] WHO Drug Information, Vol. 36, No. 2, 2022 |
| | 2,4(1H,3H)-Pyrimidinedione, 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-, (-)- Preparation Products And Raw materials |
|